Genentech

Highly Engaged Employees

Genentech, established in 1976, stands as a cornerstone of the global biotechnology industry. Headquartered in South San Francisco, California, the firm specializes in the research and development of innovative biopharmaceuticals designed to address serious medical conditions. By leveraging advanced scientific methodologies, Genentech focuses on personalized healthcare, cancer immunotherapy, and synthetic human insulin production to improve patient outcomes. The company maintains a robust pipeline of clinical trials and medical treatments, positioning itself as a leader in the life sciences sector.

With a workforce exceeding 10,000 employees, Genentech operates across 21 distinct locations to support its extensive R&D and commercial activities. The organization emphasizes a culture of scientific excellence and professional development, fostering a collaborative environment for its diverse team of researchers and medical professionals. Meet Genentech's team to gain insights into the leadership and organizational structure driving these complex operations. Their commitment to patient advocacy and information support remains central to their operational strategy, ensuring that therapeutic advancements reach those in need through efficient clinical engagement and specialized transportation services.

Genentech demonstrates significant market presence with annual revenues reaching $2.5B. The company competes with major industry players such as Amgen, Gilead Sciences, and Biogen, maintaining a competitive edge through continuous innovation in bio-pharmaceuticals. Explore financial highlights to review detailed metrics regarding their fiscal performance and funding history, including their foundational $100.0M investment from Kleiner Perkins. As a key entity in the biotechnology landscape, Genentech continues to influence global health standards through its commitment to scientific rigor and therapeutic efficacy.